User profiles for Aladdin J. Mohammad

Mohammad Aladdin J

Associate professor
Verified email at med.lu.se
Cited by 4406

[HTML][HTML] Global epidemiology of vasculitis

…, G Hatemi, JC Burns, AJ Mohammad - Nature reviews …, 2022 - nature.com
The many forms of vasculitis are characterized by inflammation of blood vessels, leading to
potentially long-term sequelae including vision loss, aneurysm formation and kidney failure. …

Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

RA Watts, A Mahr, AJ Mohammad… - Nephrology Dialysis …, 2015 - academic.oup.com
It is now 25 years since the first European studies on vasculitis—the anti-neutrophil
cytoplasmic antibody (ANCA) standardization project. Over that period of time, there have been …

[HTML][HTML] Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review

A Sharma, AJ Mohammad, C Turesson - Seminars in Arthritis and …, 2020 - Elsevier
Background Giant cell arteritis (GCA; sometimes referred to as temporal arteritis) and
polymyalgia rheumatica (PMR) are common and interrelated inflammatory conditions that almost …

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa

AJ Mohammad, LTH Jacobsson, KWA Westman… - …, 2009 - academic.oup.com
Objective. To estimate the incidence of and survival rates for WG, microscopic polyangiitis (MPA),
Churg–Strauss syndrome (CSS) and PAN within a defined population in southern …

Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study

…, D Roccatello, A Vacca, AJ Mohammad… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

…, A Mahr, PA Merkel, AJ Mohammad… - Annals of the …, 2024 - ard.bmj.com
Background Since the publication of the EULAR recommendations for the management of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …

An update on the epidemiology of ANCA-associated vasculitis

AJ Mohammad - Rheumatology, 2020 - academic.oup.com
ANCA-associated vasculitis (AAV) includes granulomatosis with polyangiitis, microscopic
polyangiitis and eosinophilic granulomatosis with polyangiitis. Epidemiological studies in AAV …

Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden

AJ Mohammad, JÅ Nilsson, LTH Jacobsson… - Annals of the …, 2015 - ard.bmj.com
Objectives To study the epidemiology and mortality in patients with biopsy-proven giant cell
arteritis (GCA) in southern Sweden. Methods The study area was the County of Skåne. …

An update on polymyalgia rheumatica

…, A Sharma, C Turesson, AJ Mohammad - Journal of Internal …, 2022 - Wiley Online Library
Mohammad was supported by grants from The Swedish Research Council, ALF Medel Skåne,
Aladdin J. Mohammad has received honoraria for lectures and educational events from …

A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)–associated nephritis versus myeloperoxidase …

AJ Mohammad, M Segelmark - The Journal of rheumatology, 2014 - jrheum.org
Objective. Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) is usually
differentiated based on clinical phenotypes, but recent data indicate that myeloperoxidase (…